Picture of Angle logo

AGL — Angle Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-4.16%
3m+5.82%
6m-17.49%
1yr-10.75%
Volume Change (%)
10d/3m+2.28%
Price vs... (%)
52w High-28.13%
50d MA+7.09%
200d MA-7.96%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-40.89%
Return on Equity-40.21%
Operating Margin-1701.38%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for AGL

Momentum investing with Angle (LON:AGL) background image

Momentum investing with Angle (LON:AGL)

Intriguing research into stock market price trends shows that investors behave strangely when a stock trades close to its 52-week high... Despite flying high, holders of the shares are more likely to sell out and snatch a profit than h...

Which way to trade Angle (LON:AGL)? background image

Which way to trade Angle (LON:AGL)?

As any reader of this is probably aware, shares in Angle (LON:AGL) are currently trading close to a 52 week high, with the share price up by around 3.39% to 88.89 over the past week. On a one-month basis, the Angle price has risen by 6...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Angle EPS forecast chart

Profile Summary

ANGLE plc is a United Kingdom-based specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. The Company’s lead product is the Parsortix cell separation system, which captures very rare cells from the blood. This includes circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The Company’s translational research includes ovarian cancer, breast cancer, prostate cancer and small cell lung cancer.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
December 4th, 2003
Public Since
March 17th, 2004
No. of Employees
102
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
235,149,717

AGL Share Price Performance

Latest News for AGL

Upcoming Events for AGL

Half Year 2022 Angle PLC Earnings Release

Similar to AGL

Picture of Abingdon Health logo

Abingdon Health

gb flag iconLondon Stock Exchange

Picture of Advanced Medical Solutions logo

Advanced Medical Solutions

gb flag iconLondon Stock Exchange

Picture of Advanced Oncotherapy logo

Advanced Oncotherapy

gb flag iconLondon Stock Exchange

Aptamer

gb flag iconLondon Stock Exchange

Picture of Belluscura logo

Belluscura

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email